Cas no 81528-65-6 (N-(3-methylpyridin-2-yl)ethane-1,2-diamine)

N-(3-methylpyridin-2-yl)ethane-1,2-diamine structure
81528-65-6 structure
Product Name:N-(3-methylpyridin-2-yl)ethane-1,2-diamine
CAS No:81528-65-6
MF:C8H13N3
MW:151.208921194077
MDL:MFCD09802320
CID:703777
PubChem ID:329775743
Update Time:2025-04-23

N-(3-methylpyridin-2-yl)ethane-1,2-diamine Chemical and Physical Properties

Names and Identifiers

    • N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine
    • 1,2-Ethanediamine, N-(3-methyl-2-pyridinyl)-
    • N'-(3-methylpyridin-2-yl)ethane-1,2-diamine
    • N-(3-METHYLPYRIDIN-2-YL)ETHANE-1,2-DIAMINE
    • AKOS011536954
    • 81528-65-6
    • DTXSID10510640
    • BS-36954
    • N~1~-(3-Methylpyridin-2-yl)ethane-1,2-diamine
    • SCHEMBL8345840
    • CS-0362437
    • (2-AMINOETHYL)(3-METHYL-2-PYRIDINYL)AMINE
    • N-(3-Methylpyridin-2-yl)ethane-1,2-diamine, AldrichCPR
    • MFCD09802320
    • N-(3-methylpyridin-2-yl)ethane-1,2-diamine
    • MDL: MFCD09802320
    • Inchi: 1S/C8H13N3/c1-7-3-2-5-10-8(7)11-6-4-9/h2-3,5H,4,6,9H2,1H3,(H,10,11)
    • InChI Key: FOMZKRMMBHSXRG-UHFFFAOYSA-N
    • SMILES: N(C1C(C)=CC=CN=1)CCN

Computed Properties

  • Exact Mass: 151.11100
  • Monoisotopic Mass: 151.110947427g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 3
  • Complexity: 106
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 0.6
  • Topological Polar Surface Area: 50.9?2

Experimental Properties

  • PSA: 50.94000
  • LogP: 1.53390

N-(3-methylpyridin-2-yl)ethane-1,2-diamine Security Information

  • Hazardous Material transportation number:NONH for all modes of transport
  • WGK Germany:3

N-(3-methylpyridin-2-yl)ethane-1,2-diamine Customs Data

  • HS CODE:2933399090
  • Customs Data:

    China Customs Code:

    2933399090

    Overview:

    2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

N-(3-methylpyridin-2-yl)ethane-1,2-diamine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
M103190-50mg
N-(3-methylpyridin-2-yl)ethane-1,2-diamine
81528-65-6
50mg
$ 50.00 2022-06-04
TRC
M103190-100mg
N-(3-methylpyridin-2-yl)ethane-1,2-diamine
81528-65-6
100mg
$ 65.00 2022-06-04
TRC
M103190-500mg
N-(3-methylpyridin-2-yl)ethane-1,2-diamine
81528-65-6
500mg
$ 230.00 2022-06-04
XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd.
CBR01323-1G
N-(3-Methylpyridin-2-yl)ethane-1,2-diamine
81528-65-6
1g
¥3340.6 2023-11-13
Chemenu
CM283564-5g
N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine
81528-65-6 95%
5g
$659 2022-06-10
eNovation Chemicals LLC
Y1253381-1g
1,2-Ethanediamine, N-(3-methyl-2-pyridinyl)-
81528-65-6 95%
1g
$255 2024-06-07
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1433107-250mg
N1-(3-methylpyridin-2-yl)ethane-1,2-diamine
81528-65-6 95+%
250mg
¥1404.00 2024-07-28
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1433107-1g
N1-(3-methylpyridin-2-yl)ethane-1,2-diamine
81528-65-6 95+%
1g
¥2520.00 2024-07-28
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1433107-5g
N1-(3-methylpyridin-2-yl)ethane-1,2-diamine
81528-65-6 95+%
5g
¥7171.00 2024-07-28
eNovation Chemicals LLC
Y1253381-1g
1,2-Ethanediamine, N-(3-methyl-2-pyridinyl)-
81528-65-6 95%
1g
$255 2025-02-20

Additional information on N-(3-methylpyridin-2-yl)ethane-1,2-diamine

Introduction to N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine (CAS No. 81528-65-6)

N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This compound, identified by the CAS number 81528-65-6, has garnered considerable attention due to its potential applications in drug development and biochemical research. The molecular structure of this compound includes a pyridine ring substituted with a methyl group at the 3-position and an ethane-1,2-diamine moiety at the 1-position, which contributes to its versatile reactivity and biological activity.

The synthesis of N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine involves a series of well-defined chemical reactions that highlight the compound's synthetic accessibility. The presence of the pyridine ring enhances its interaction with various biological targets, making it a valuable scaffold for designing novel therapeutic agents. Recent advancements in medicinal chemistry have demonstrated the utility of this compound in developing inhibitors targeting specific enzymes and receptors involved in metabolic and inflammatory pathways.

One of the most compelling aspects of N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine is its role in the development of small-molecule drugs. The compound's ability to modulate the activity of enzymes such as kinases and phosphodiesterases has been explored in several preclinical studies. These studies have shown that derivatives of this compound exhibit promising pharmacological effects, including anti-inflammatory and anti-cancer properties. The ethane-1,2-diamine moiety, in particular, contributes to its binding affinity and selectivity towards biological targets.

Recent research has also highlighted the importance of N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine in understanding drug-drug interactions. Its structural features allow it to interact with multiple binding sites on target proteins, which can influence the efficacy and safety of co-administered drugs. This property makes it a valuable tool for studying complex pharmacokinetic interactions and for designing combination therapies that maximize therapeutic outcomes.

The compound's potential extends beyond its applications in drug development. It has been investigated as a key intermediate in the synthesis of more complex molecules with diverse biological activities. The versatility of N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine lies in its ability to serve as a building block for constructing novel scaffolds that can be further modified to achieve specific pharmacological effects.

In conclusion, N1-(3-Methylpyridin-2-yl)ethane-1,2-diamine (CAS No. 81528-65-6) is a multifaceted compound with significant implications in pharmaceutical chemistry and biochemical research. Its unique structural features and biological activities make it a valuable candidate for developing new therapeutic agents and understanding complex drug interactions. As research continues to uncover new applications for this compound, its importance in advancing medical science is likely to grow.

Recommended suppliers
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
Shanghai Jinhuan Chemical CO., LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Jinhuan Chemical CO., LTD.
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.